UniProtKB/SwissProt variant VAR

Variant information

Variant position:

561

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LB/B

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Tryptophan (W) at position 561 (R561W, p.Arg561Trp).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and basic (R) to large size and aromatic (W)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-3

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Other resources:

Links to websites of interest for the variant.

Variant rs4314 [ dbSNP | Ensembl ]

Sequence information

Variant position:

561

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

1306

The length of the canonical sequence.

Location on the sequence:

HEALCKEAGYEGPLHQCDIY R STKAGAKLRKVLQAGSSRPW

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         HEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPW

Chimpanzee                    HEALCKEAGYEGPLHQCDIYQSTKAGAKLRKVLQAGSSRPW

Mouse                         HQALCKEAGHQGPLHQCDIYQSAQAGAKLKQVLQAGCSRPW

Rat                           HQALCKEAGHQGPLHQCDIYQSTKAGAKLQQVLQAGCSRPW

Rabbit                        HQALCMEAGHQGPLHQCDIYQSTRAGAKLRAVLQAGCSRPW

Drosophila                    ----------------CD-----------------------

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	30 – 1306	Angiotensin-converting enzyme
Chain	30 – 1232	Angiotensin-converting enzyme, soluble form
Topological domain	30 – 1256	Extracellular
Region	30 – 630	Peptidase M2 1
Alternative sequence	1 – 641	MGAASGRRGPGLLLPLPLLLLLPPQPALALDPGLQPGNFSADEAGAQLFAQSYNSSAEQVLFQSVAASWAHDTNITAENARRQEEAALLSQEFAEAWGQKAKELYEPIWQNFTDPQLRRIIGAVRTLGSANLPLAKRQQYNALLSNMSRIYSTAKVCLPNKTATCWSLDPDLTNILASSRSYAMLLFAWEGWHNAAGIPLKPLYEDFTALSNEAYKQDGFTDTGAYWRSWYNSPTFEDDLEHLYQQLEPLYLNLHAFVRRALHRRYGDRYINLRGPIPAHLLGDMWAQSWENIYDMVVPFPDKPNLDVTSTMLQQGWNATHMFRVAEEFFTSLELSPMPPEFWEGSMLEKPADGREVVCHASAWDFYNRKDFRIKQCTRVTMDQLSTVHHEMGHIQYYLQYKDLPVSLRRGANPGFHEAIGDVLALSVSTPEHLHKIGLLDRVTNDTESDINYLLKMALEKIAFLPFGYLVDQWRWGVFSGRTPPSRYNFDWWYLRTKYQGICPPVTRNETHFDAGAKFHVPNVTPYIRYFVSFVLQFQFHEALCKEAGYEGPLHQCDIYRSTKAGAKLRKVLQAGSSRPWQEVLKDMVGLDALDAQPLLKYFQPVTQWLQEQNQQNGEVLGWPEYQWHPPLPDNYPEGID -> MGQGWATAGLPSLLFLLLCYGHPLLVPSQEASQQVTVTHGTSSQATTSSQTTTHQATAHQTSAQSPN. In isoform 4.
Alternative sequence	1 – 574	Missing. In isoform Testis-specific.

Literature citations

Sequence variation in the human angiotensin converting enzyme.
Rieder M.J.; Taylor S.L.; Clark A.G.; Nickerson D.A.;
Nat. Genet. 22:59-62(1999)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS SER-261; TRP-561 AND SER-1286;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12821: Variant p.Arg561Trp